We aimed to develop a nomogram using serum biomarkers (CA125 and HE4), and clinical variables (such as age, gender, estimated glomerular filtration rate (eGFR), medical history for early detection of UC in CKD patients. This evidence concerns the gene WFDC2 and chronic kidney disease.